Significance Analysis of Prognostic Signatures

Andrew H. Beck; Nicholas W. Knoblauch; Marco M. Hefti; Jennifer Kaplan; Stuart J. Schnitt; Aedin C. Culhane; Markus S. Schroeder; Thomas Risch; John Quackenbush; Benjamin Haibe-Kains

doi:10.1371/journal.pcbi.1002875

Loading metrics

Open Access

Peer-reviewed

Research Article

Significance Analysis of Prognostic Signatures

Andrew H. Beck ,

* E-mail: abeck2@bidmc.harvard.edu (AHB); bhaibeka@ircm.qc.ca (BHK)

Affiliation Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Nicholas W. Knoblauch,

Affiliation Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Marco M. Hefti,

Affiliation Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Jennifer Kaplan,

Affiliation Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Stuart J. Schnitt,

Affiliation Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Aedin C. Culhane,

Affiliations Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯
Markus S. Schroeder,

Affiliations Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯
Thomas Risch,

Affiliations Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯
John Quackenbush,

Affiliations Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America, Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Benjamin Haibe-Kains

* E-mail: abeck2@bidmc.harvard.edu (AHB); bhaibeka@ircm.qc.ca (BHK)

Affiliation Bioinformatics and Computational Genomics Laboratory, Institut de Recherches Cliniques de Montréal (IRCM), Montreal, Quebec, Canada
⨯

Significance Analysis of Prognostic Signatures

Andrew H. Beck,
Nicholas W. Knoblauch,
Marco M. Hefti,
Jennifer Kaplan,
Stuart J. Schnitt,
Aedin C. Culhane,
Markus S. Schroeder,
Thomas Risch,
John Quackenbush,
Benjamin Haibe-Kains

Published: January 24, 2013
https://doi.org/10.1371/journal.pcbi.1002875

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Ovarian cancer
Is the Subject Area "Ovarian cancer" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.
Hypoxia
Is the Subject Area "Hypoxia" applicable to this article?

Thanks for your feedback.
Cancer genomics
Is the Subject Area "Cancer genomics" applicable to this article?

Thanks for your feedback.
Hierarchical clustering
Is the Subject Area "Hierarchical clustering" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.